---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-24-001079"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:34:48.409173+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Immunic extends Executive Chairman Dr. Duane Nash's term to Dec 2025 with salary increase

## Summary
- Term of Executive Chairman Duane Nash extended to December 31, 2025 via Addendum No. 6.
- Monthly base salary raised to $33,987 from $32,368, inclusive of board retainer.
- Addendum effective August 29, 2024; all other employment terms unchanged.

## SEC filing metadata
- accession: 0001193805-24-001079
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/0001193805-24-001079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380524001079/e663859_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-24-001079
- JSON: https://secwatch.observer/filing/0001193805-24-001079.json
- Plain text: https://secwatch.observer/filing/0001193805-24-001079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.